Precede Biosciences

About:

Precede Biosciences is breaking down the barriers to precision medicine by redefining what can be gleaned from a simple blood draw.

Website: https://www.precede.bio

Twitter/X: Precede_Bio

Top Investors: Bristol-Myers Squibb, Lilly Asia Ventures, OUP (Osage University Partners), 5AM Ventures, Qatar Investment Authority

Description:

Precede Biosciences is breaking down the barriers to precision medicine by redefining what can be gleaned from a simple blood draw. Precede aims to increase drug development success rates and to contribute to a future in which every patient can receive a speedy, minimally invasive diagnosis and therapy tailored to the biology of their condition.

Total Funding Amount:

$57M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2005-01-01

Contact Email:

INFO(AT)PRECEDE.BIO

Founders:

Rehan Verjee

Number of Employees:

11-50

Last Funding Date:

2023-10-05

IPO Status:

Private

Industries:

© 2025 bioDAO.ai